Correlation Engine 2.0
Clear Search sequence regions


  • apolipoproteins e (2)
  • brain (3)
  • dna helicases (2)
  • family (4)
  • female (1)
  • gene expressed (1)
  • human (2)
  • NAV2 (6)
  • nervous system (1)
  • neuron (1)
  • protein human (1)
  • rna (2)
  • rs12364788 (1)
  • rs1354269 (1)
  • rs17614100 (1)
  • rs7112354 (1)
  • ten (2)
  • Sizes of these terms reflect their relevance to your search.

    The neuron navigator 2 (NAV2) gene is highly expressed in brain and involved in the nervous system development and may play a role in Alzheimer's disease (AD). We aimed to investigate the associations of 317 single-nucleotide polymorphisms (SNPs) in the NAV2 gene with the risk and age at onset (AAO) of AD using a family-based sample (1266 AD cases and 1279 healthy relatives). Association with the risk of AD was assessed using family-based association test -generalized estimating equations (FBAT- GEE) statistics while the association with AAO as a quantitative trait was evaluated using the FBAT-Wilcoxon statistic. Single marker analysis showed that 20 SNPs were significantly associated with the risk of AD (top SNP rs7112354 with p=8.46×10-4) and 11 SNPs were associated with AAO (top SNP rs1354269 with p=2.87×10-3). Interestingly, two SNPs rs17614100 and rs12364788 were associated with both the risk (p=1.7×10-2 and 2.71×10-2; respectively) and AAO (p=1.85×10-3 and 6.06×10-3; respectively). Haplotype analyses further supported the results of single marker analyses. In addition, functional analysis showed that NAV2 mRNA had significant expression across ten human brain regions examined and significantly correlated with APOE expression in four of ten regions. The present study is the first study providing evidence of several genetic variants within the NAV2 gene influencing the risk and AAO of AD. Copyright © 2017 Elsevier B.V. All rights reserved.

    Citation

    Ke-Sheng Wang, Ying Liu, Chun Xu, Xuefeng Liu, Xingguang Luo. Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease. Journal of neuroimmunology. 2017 Sep 15;310:60-65

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28778446

    View Full Text